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TranscriptionRA receptors (RARs) have been thought to function through a binary repressor–activator mechanism: in the
absence of ligand, they function as transcriptional repressors, and, in the presence of ligand, they function as
transcriptional activators. This prevailing model of RAR mechanism has been derived mostly from in vitro
studies and has not been widely tested in developmental contexts. Here, we investigate whether zebraﬁsh
RARs function as transcriptional activators or repressors during early embryonic anterior–posterior
patterning. Ectopic expression of wild-type zebraﬁsh RARs does not disrupt embryonic patterning and does
not sensitize embryos to RA treatment, indicating that RAR availability is not limiting in the embryo. In
contrast, ectopic expression of hyperactive zebraﬁsh RARs induces expression of a RA-responsive reporter
transgene as well as ectopic expression of endogenous RA-responsive target genes. However, ectopic
expression of dominant negative zebraﬁsh RARs fails to induce embryonic phenotypes that are consistent
with loss of RA signaling, despite their ability to function as transcriptional repressors in heterologous cell
culture assays. Together, our studies suggest that zebraﬁsh RAR function is context-dependent and that,
during early patterning, zebraﬁsh RARs function primarily as transcriptional activators and may only have
minimal ability to act as transcriptional repressors. Thus, it seems that the binary model for RAR function does
not apply to all in vivo scenarios. Taking into account studies of RA signaling in tunicates and tetrapods, we
propose a parsimonious model of the evolution of RAR function during chordate anterior–posterior
patterning.ences, University of California,
12.
Division, Cincinnati Children's
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Retinoic acid (RA) signaling regulates a diverse array of develop-
mental processes. One of its well-known roles is in determining
anterior–posterior (A–P) positional identity during early development,
through regulation of Hox gene expression (Marletaz et al., 2006). In
addition to the early role of RA signaling during A–P patterning, it has
later roles in growth, homeostasis and patterning of numerous organs
(Capdevila and Izpisua Belmonte, 2001; Kastner et al., 1997; Lohnes
et al., 1994;Mendelsohn et al., 1994; Niederreither and Dolle, 2008). RA
signaling requires RA receptors (RARs), members of the nuclear
hormone family of receptors, of which there are 3 paralogs (alpha,
beta and gamma) in mammals (Aranda and Pascual, 2001; Bastien and
Rochette-Egly, 2004). Zebraﬁsh have 4 RARs: species-speciﬁc paralogs
of the RARalphas (RARaa and ab) and gammas (RARga and gb), but no
beta ortholog (Hale et al., 2006;Waxman andYelon, 2007). In bothmiceand zebraﬁsh, there is a high degree of functional redundancy between
RARs in early development, although there are some requirements for
individual receptors (Linville et al., 2009; Lohnes et al., 1994;
Mendelsohn et al., 1994).
Prior studies have proposed a binary ligand-dependent transcrip-
tional repressor-activator paradigm for RAR function (Bastien and
Rochette-Egly, 2004; Chen and Evans, 1995; Hauksdottir et al., 2003;
Perissi et al., 1999; Torchia et al., 1998; Xu et al., 1999). In the absence
of ligand (all-trans RA), the RARs are thought to interact with
transcriptional repressors. Upon the binding of RA to RARs, the
receptors then exchange the transcriptional repressors for transcrip-
tional activation machinery (Bastien and Rochette-Egly, 2004; Chen
and Evans, 1995; Hauksdottir et al., 2003; Perissi et al., 1999; Torchia
et al., 1998; Xu et al., 1999). However, this binary model is primarily
derived from studies in cell culture and has not been tested in most
developmental contexts. So far, there are only two in vivo develop-
mental contexts in which RARs have been shown to be required as
transcriptional repressors: Xenopus midbrain–hindbrain boundary
(MHB) formation and mouse skeletal growth (Koide et al., 2001;
Williams et al., 2009). In Xenopus embryos, depletion of RARa results
in loss of the MHB, similar to the effect of adding RA (Koide et al.,
2001). This phenotype can be rescued by expression of a dominant
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this context, consistent with the binary model. More recently, it has
been demonstrated that the shortened limbs in mouse RAR knockouts
are due to a requirement for RAR transcriptional repressor activity in
skeletal growth plates (Williams et al., 2009). These phenotypes are
reminiscent of transgenic mice that overexpress a constitutively
active RAR in the limb, supporting a repressive role of RA signaling in
the limb (Cash et al., 1997). Moreover, these in vivo studies echo in
vitro studies in which RAR-mediated transcriptional repression is
required for chondrogenic mesenchyme differentiation in murine
primary cultures (Weston et al., 2002, 2000).
Despite these characterized roles as transcriptional repressors,
many of the developmental phenotypes caused by loss of RARs have
been interpreted as representing failure to activate RAR target genes,
rather than representing failure to repress RAR target genes (Lohnes
et al., 1994; Mendelsohn et al., 1994). Furthermore, transgenic mice
expressing dominant negative RARs only exhibit a subset of
phenotypes associated with the loss of RARs, even though transgene
expression should be fairly broad (Damm et al., 1993; Iulianella and
Lohnes, 2002). Likewise, studies in zebraﬁsh embryos seem inconsis-
tent with a requirement for RARs acting as transcriptional repressors.
For instance, depletion of RARs does not seem to inhibit MHB
formation (Linville et al., 2009), in contrast to what has been shown
for Xenopus (Koide et al., 2001). Instead, expression of a zebraﬁsh
dnRAR together with injection of anti-RAR morpholinos exacerbates
other phenotypes caused by RA deﬁciency (Stafford and Prince, 2002).
Therefore, studies in bothmouse and zebraﬁsh hint that RARsmay not
be required to function as transcriptional repressors or via the binary
model in all developmental contexts.
Here, we more rigorously examine the mechanism of transcrip-
tional regulation by RARs during early A–P patterning of the zebraﬁsh
embryo using three different assays: novel transgenic reporters of RA
signaling, endogenous target genes downstream of RA signaling, and
embryonic phenotypes dependent on RA signaling. We show that
ectopic expression of wild-type zebraﬁsh RARs neither blocks nor
activates expression of RA-responsive targets in the early embryo, nor
does it sensitize the embryo to addition of RA. In contrast, ectopic
expression of hyperactive VP16-tagged zebraﬁsh RARs is able to cause
phenotypes similar to those caused by increased RA signaling.
However, dominant negative zebraﬁsh RARs (dnRARs) are not able
to act as transcriptional repressors in the early embryo, even though
they can repress transcription in heterologous cell culture assays,
suggesting that zebraﬁsh RARs have minimal repressive ability during
early A–P patterning. Altogether, these results suggest a model in
which the ability of zebraﬁsh RARs to function as transcriptional
repressors or activators is context-dependent. Speciﬁcally, during
early A–P patterning, the zebraﬁsh RARs function primarily as
transcriptional co-activators to regulate target gene expression.
Materials and methods
Construction of VP16 chimeras, Engrailed repressor chimeras, and
dominant negative RARs
Sequences for wild-type zebraﬁsh RARs have been reported
previously (Waxman and Yelon, 2007). For full-length RAR-VP16
chimeric proteins (generally referred to as RAR-vps), the VP16 activator
domain was fused directly to the N or C terminus, with the only
modiﬁcations being the deletion of the start or termination codons of
the RARs. For ΔA domain chimeras with RARab, amino acids 1–47 were
deleted and the VP16 activator or Engrailed repressor (Enr) domains
were fused to amino acid 48 (H). For the ΔA domain chimera with
RARga, amino acids 1–41 were deleted and the VP16 activator domain
was fused to aminoacid42 (T). ForΔF domain chimeraswithRARab, the
VP16 activator or Enr domainswere placed after amino acid 410 (E). For
the ΔF domain fusion with RARga, the VP16 activator domain wasplaced after amino acid 406 (E). A dominant negative (dn) RARab was
made by truncating the protein at amino acid 398 (P), and a dnRARga
was made by truncating the protein at amino acid 394 (G), as reported
by Damm et al. (1993) for murine RARa and RARg. All fusion and
truncation constructs were generated using PCR and conﬁrmed by
sequencing. Primer sequences are available upon request. pSP72 human
dnRARa, a gift of C. Sagerström, has been reported previously (Roy and
Sagerström,2004). ZebraﬁshdnRARaa, a gift of T. Schilling,was reported
previously (Stafford et al., 2006).All untaggedRARsused in experiments
were subcloned into pCS2p+, except dnRARaa, which was in pCS2. For
addition of myc tags, RARswere subcloned into pCS2+MT (Rupp et al.,
1994). EndogenousUTRswere omitted fromall constructs in aneffort to
normalize levels of ectopic expression for all RARs.
Embryo injections
Embryos were injected at the 1 cell stage for all experiments, except
Western blots and wholemount immunoﬂuorescence, for which
embryos were injected as late as the 4 cell stage. Capped mRNA was
made using the Message Machine Kit (Ambion). For all mRNAs, we
titrated the amount of mRNA injected and sought to inject the lowest
possible dose that produced the maximal phenotypic response
consistent with altered RA signaling. For constructs that seemed to
cause no overt phenotype, we therefore needed to use the highest dose
possible (200 pg), which borders on levels that are typically toxic.
Following titration, 100 pg ofmRNAwas injected for all constructs used,
unless otherwise indicated. For dnrar and rarabΔF-enr chimeras, we
injected200 pgofmRNA. For humandnrara,we injected80 pgofmRNA.
For zebraﬁsh rarab-ΔAenr, only 50 pg of mRNA was injected because
higher amounts cause aberrant gastrulation movements and cyclopia,
phenotypes which are not typical for loss of RA signaling. For all other
mRNAs, these non-speciﬁc phenotypes, in addition to kinking of the tail,
were seen at doses higher than 200 pg.
In situ hybridization
In situ hybridization probes for dhrs3a (ZDB-GENE-040801-217),
hoxb5b (ZDB-GENE-000823-6), opl/zic1 (ZDB-GENE-000208-4), eng2a
(ZDB-GENE-980526-167), krox20/egr2b (ZDB-GENE-980526-283), and
myod (ZDB-GENE-980526-561) have been reported previously.
Construction of 12X RARE reporter transgenes and transgenic lines
The 12X RARE reporters (12XRARE-ef1a:gfp and 12XRARE-tk:gfp)
feature the concatenation of 12 direct repeat 5 (DR5) retinoic acid
response element (RARE) sites (binding sites for the RARs). RARE sites
weremodeled after those found in theHox gene promoters and varied
in their 5 nucleotide spacer sequence (Bastien and Rochette-Egly,
2004). Six 5′ RAREs were placed in the reverse orientation and six 3′
RAREs were placed in the forward orientation (Fig. 1A). All RARE sites
were placed upstream of either an elongation factor-1 alpha (ef1a) or
thymidine kinase (tk) minimal promoter within a vector containing
egfp ﬂanked by adeno-associated viral inverted terminal repeat
elements and I-SceI sites (gift of D. Prober; Prober et al., 2006).
Sequences of reporter transgenes are available upon request.
Transgenic lines were made as previously reported (Prober et al.,
2006). Brieﬂy, ~100 pg of RARE reporter transgene plasmid was
digested with I-SceI and injected into embryos at the 1 cell stage.
These embryos were raised to adulthood, and their progeny were
screened for ﬂuorescence.
RA treatment and pharmacological reagents
For analysis of responsiveness of the Tg(12XRARE-ef1a:gfp) and
Tg(12XRARE-tk:gfp) lines, treatment with pharmacological reagents
began at 24 or 30 hours post-fertilization (hpf), respectively, and was
Fig. 1. Zebraﬁsh RARE transgenic reporter lines. (A) Schematic representation of the 12XRARE reporters. Arrows indicate direction of each DR5 RARE site. (B) At 8 somites, the
expression of gfp from Tg(12XRARE-ef1a:gfp) can be seen at low levels in the anterior spinal cord (arrowhead). At this stage, embryos require a much longer exposure to visualize gfp
expression than at subsequent stages. (C) At 14 somites, gfp expression is more easily detected in the spinal cord (arrowhead). (D) By 22 somites, the reporter is expressed at higher
levels in the pronephros (arrow) and spinal cord (arrowhead). Shortly afterward, the reporter is also expressed in the ventral eye (not shown), similar to Tg(12XRARE-tk:gfp).
(E) Expression of Tg(12XRARE-tk:gfp) does not initiate until closer to 24 hpf, when it is seen in the ventral eye (upper arrow), pronephros (lower arrow), and the anterior spinal cord
(arrowhead). (F) Expression of Tg(12XRARE-tk:gfp) in the eye (arrow) and spinal cord (arrowhead) is maintained past 48 hpf. All images are lateral views, with anterior up and
dorsal to the right.
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RA signaling, we used doses that we have previously found to cause
phenotypes consistent with loss of RA signaling when treatments
were initiated prior to gastrulation (Waxman et al., 2008). These
phenotypes include loss of forelimb (pectoral ﬁn), enlarged heart, and
hindbrain defects. For BMS189453 (BMS; Bristol-Meyers Squibb) and
DEAB (Sigma), working concentrations of 1 μM were used. For Ro41-
5253 (Biomol.com), a RARα speciﬁc antagonist, a working concen-
tration of 0.5 μM was used.
For analysis of embryos injected with zebraﬁsh RARs, embryos
were treated continuously from 40% epiboly with 0.05 μM RA. For
analysis of Tg(12XRARE-ef1a:gfp) embryos at the tailbud stage,
embryos were treated continuously beginning at 40% epiboly with
0.2 μM RA. For all other experiments involving early RA treatment,
embryos were treated for 1 h with 0.5 μM or 0.2 μM RA beginning at
40% epiboly. For AM580 treatments (Biomol.com), a RARα speciﬁc
agonist, a working concentration of 0.1 μM was used. For all other
pharmacological reagents (see Supplemental Material), working
concentrations of 1 μM were used.
Cell culture and luciferase assays
For luciferase reporter assays, the 12XRARE-ef1a and 12XRARE-tk
promoters were placed into the NotI site of the pGL3-basic vector
(Promega). HEK 293 cells were grown in DMEM supplemented with
10% fetal bovine serum and 1% Pen/Strep under standard conditions.
All assays were performed in 96 well dishes. Approximately 10,000
cells per well were transfected with a total of 0.1 μg DNA using SiPort
NEO (Ambion). For all experiments, cells were transfected with
0.025 μg of RAR and β-gal plasmids. Either 0.025 or 0.05 μg of RAREreporter plasmid and 0.025 μg of Renilla luciferase plasmid were also
included to bring the total amount of DNA transfected to 0.1 μg.
Similar results were obtained with either amount of RARE reporter
plasmid. Luminescence was read after 3 days using the Dual-Glo
system (Promega). Levels of ﬁreﬂy luciferase were standardized
relative to Renilla luciferase. For RA treatments, the media was
removed one day after transfection and replaced with media
containing either 1 μM RA or a DMSO control, and luminescence
was read at day 3.
Western blotting and wholemount immunoﬂuorescence
Western blots and wholemount immunoﬂuorescence were per-
formed essentially as described by Mintzer et al. (2001). To check the
expression of the tagged proteins, 100 pg of each of the taggedmRNAs
was injected at the 1–4 cell stage. Embryos were then lysed or ﬁxed,
respectively, forWestern blots andwholemount immunoﬂuorescence
at 70–90% epiboly. For both analyses, the monoclonal 9e10 anti-myc
antibody (Covance) was used as the primary antibody. For a loading
control, a mouse anti-α-tubulin antibody (Sigma) was used. For
Western blotting, a HRP-conjugated anti-mouse (Sigma) was used as
the secondary antibody. For wholemounts, a FITC-conjugated anti-
mouse IgG1 (Southern Biotech) was used as the secondary antibody.
Results
Characterization of transgenic reporters of RA signaling
In order to understand the mechanisms of RA signaling during early
developmental processes, it is important to examine the ability of RARs
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We therefore generated transgenes containing a synthetic RARE
reporter, in which 12 RAREs are concatenated (Fig. 1A). We henceforth
refer to the two novel synthetic RARE reporter constructs used tomake
transgenic zebraﬁsh lines as Tg(12XRARE-ef1a:gfp) and Tg(12XRARE-tk:
gfp), reﬂecting the promoter used in each construct. We analyzed 4
different Tg(12XRARE-ef1a:gfp) lines and 2 different Tg(12XRARE-tk:gfp)
lines. All recovered lines exhibited a Mendelian mode of inheritance
indicating that they likely represent insertions at single loci (JSW and
DY, unpublished data). For this study, we focus on two representative
lines Tg(12XRARE-ef1a:gfp)sk71 and Tg(12XRARE-tk:gfp)sk73.
Expression of Tg(12XRARE-ef1a:gfp) is detectable by in situ hybrid-
ization for gfp at about 8 somites (13 hpf; Fig. 1B). Despite the early
detectability of gfp RNA, which is maintained in the spinal cord through
14 somites (Fig. 1C), GFP ﬂuorescence is not detectable until about 20–
22 hpf. Fluorescence becomes progressively stronger through 30 hpf
(Fig. 2C), but is no longer clearly visible by about 3 days post-
fertilization (dpf). Expression of Tg(12XRARE-tk:gfp) does not initiate
until closer to 24hpf (Fig. 1E), but it ismaintained through5dpf (Figs. 1F
and 2D; JSW and DY, unpublished data). Therefore, the transgenic lines
differ slightly in the temporal initiation and duration of expression.
None of our transgenic lines initiated gfp expression prior to
gastrulation, similar to what has been reported previously for anotherFig. 2. Zebraﬁsh RARE transgenic reporter lines require and are responsive to RA signaling
embryos with 0.2 μM RA induces reporter expression. (C, D) Tg(12XRARE-ef1a:gfp) and Tg(12
30 hpf (D). Untreated sibling embryos (left) exhibit expression in the anterior spinal cord (ar
more modest response than does treatment with 0.5 μM RA (right). Increased ﬂuoresce
(arrowheads) and pronephros (lower arrow). (E, H) Untreated Tg(12XRARE-ef1a:gfp) (E
antagonists BMS (F, I) and DEAB (G, J) inhibit expression of Tg(12XRARE-ef1a:gfp) and Tg(12
24 hpf (E–G) or 30 hpf (H–J). All images are lateral views, with anterior up and dorsal to thtransgene (Perz-Edwards et al., 2001), suggesting that this may be a
common characteristic of the responsiveness of synthetic RARE
reporters in zebraﬁsh.
The spatial expression of the reporter appeared similar in all
isolated transgenic lines, with major sites of expression apparent in
the anterior spinal cord, the ventral eye, and the pronephros by 24 hpf
(Figs. 1D–F and 2E, H; JSW and DY, data not shown). The only minor
difference detected was that Tg(12XRARE-tk:gfp) lines had low levels
of expression in the anterior notochord (JSW and DY, data not
shown). This difference was also found in previous zebraﬁsh RARE
transgenic reporter lines, which also compared the use of ef1a and tk
promoters (Perz-Edwards et al., 2001). In contrast to some of the
previously reported lines (Perz-Edwards et al., 2001), we did not
observe expression in other mesodermal derivatives, such as the
somites, heart, and pharyngeal arches, or in the dorsal retina.
To determine if our transgenic lines are responsive to RA signaling,
we treated transgenic embryos with RA. Exposure of Tg(12XRARE-
ef1a:gfp) embryos to RA from 40% epiboly (5 hpf) until tailbud stage
(tb; 10 hpf) induced ectopic transgene expression (Figs. 2A, B).
However, Tg(12XRARE-tk:gfp) embryos did not respond to early
treatment with RA (JSW and DY, unpublished data). Despite their
difference in early responsiveness, both reporter lines responded to
treatment with RA beginning at later stages (Figs. 2C, D).. (A) Untreated Tg(12XRARE-ef1a:gfp) embryo. (B) Treatment of Tg(12XRARE-ef1a:gfp)
XRARE-tk:gfp) embryos respond to treatment with RA for 6 h beginning at 24 hpf (C) or
rowhead), the ventral eye, and pronephros. Treatment with 0.2 μMRA (center) causes a
nce is induced in the anterior brain/eye (upper arrow), midbrain and spinal cord
) and Tg(12XRARE-tk:gfp) (H) embryos, respectively. Treatment with RA signaling
XRARE-tk:gfp). Embryos were treated with RA signaling antagonists for 6 h beginning at
e right.
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treating embryos with the RA signaling antagonists BMS 189453
(BMS), a pan-RAR inhibitor, and DEAB, an inhibitor of RA synthesis
(Russo et al., 1988; Schulze et al., 2001). Treatment with either of
these RA signaling antagonists eliminated reporter expression
(Figs. 2E–J). Other antagonists and agonists of RA signaling were
also able to affect reporter expression, while pharmacological
reagents speciﬁc to other nuclear hormone receptors did not affect
reporter expression (Fig. S1). Therefore, although the transgenic
reporters do not seem to respond at all sites of endogenous RA
signaling, both reporter lines are capable of responding to RA and can
be used as tools to better understand RA signaling.
Hyperactive zebraﬁsh RARs differentially affect developmental processes
We next used these tools to aid us in analyzing the mechanisms of
zebraﬁsh RAR function within the context of the embryo. First, we
examined the effects of overexpressing two of the wild-type (WT)
zebraﬁsh RARs (RARab and RARga) in Tg(12XRARE-ef1a:gfp) embryos.
Prior studies in cell culture have shown that RARs interact with and act
as transcriptional repressors in the absence of RA (Chen and Evans,
1995; Hauksdottir et al., 2003; Perissi et al., 1999), suggesting that
embryonic ectopic expression of WT RARs might cause phenotypes
consistent with loss of RA signaling. However, embryos injected with
rarab or rarga mRNA appeared normal at 48 hpf and beyond, and
expression of the transgene and endogenous target genes was not
affected (Figs. 3B–D; JSW and DY, unpublished data). Furthermore,
embryos injected with either of thesemRNAs and treated with RAwere
notmore severelyposteriorized anddid not activate the transgenemore
than uninjected embryos treated with RA (Figs. 3E–G), as might have
been expected from cell culture experiments (Bastien and Rochette-
Egly, 2004; Chen and Evans, 1995; Hauksdottir et al., 2003; Perissi et al.,
1999; Torchia et al., 1998; Xu et al., 1999). The inability ofWT zebraﬁsh
RARs to repress transcription or sensitize embryos to RA treatment does
not seem to be due to failure of protein expression, as tagged versions of
theseproteins canbe robustly expressed in embryos (Fig. S2). Therefore,
availability of RARs within the zebraﬁsh embryo is not a limiting factor
in the regulation of transcription in response to RA signaling; more
likely, RA availability, along with the availability of RAR-interacting
transcriptional modiﬁers, is the major limitation.
The binary repressor–activatormodel predicts that interactionswith
other transcriptional regulators underlie the regulatory roles of RARs. If
interactions of RARs with transcriptional activators modify their
functions, then RAR–VP16 fusion proteins should affect the abilities ofFig. 3. Ectopic expression of zebraﬁsh RARs does not sensitize embryos to RA signaling. (
(12XRARE-ef1a:gfp) embryo. (C, D) Tg(12XRARE-ef1a:gfp) embryos injected with zebraﬁsh ra
(12XRARE-ef1a:gfp) embryo continuously treatedwith 0.05 μMRA. (F, G) Tg(12XRARE-ef1a:gf
RA are not more affected than uninjected embryos. All images are lateral views, with anterRARs to control the transcription of RA-responsive targets. We ﬁrst
tested zebraﬁsh versions of previously reported “constitutively active”
RARs, inwhich theVP16domainwas fused directly to theN-terminus of
an RAR (Blumberg et al., 1997; Koide et al., 2001). Because A domains of
nuclear hormone receptors can modify transcriptional ability (Bastien
andRochette-Egly, 2004;Mark et al., 2006;Nagpal et al., 1992),wewere
not sure whether this zebraﬁsh version of the previously reported
VP–RAR fusion (here termed a Nvp construct; Fig. 3A) would be an
optimal indicator of activator activity. Therefore, we also made fusion
proteins inwhich theVP16domainwas fuseddirectly to theC-terminus,
to theBdomain, or to theEdomain of eachRAR (here termedCvp,ΔAvp,
and ΔFvp constructs, respectively; Fig. 3A). We found that all of the
RAR–vp constructs were able to induce ectopic reporter expression by
8 somites, although induction by the RARga–Cvp was very weak
(Figs. 4A–E, K–M; and 5A1–I1). Ectopic expression was maintained
through 24 hpf (Figs. S3 and S4). Comparing trends of transgene
activation by the different fusion proteins, the RAR–ΔAvp fusion
proteins (RARab–ΔAvp and RARga–ΔAvp) produced the strongest
activation, although RARab–ΔAvp activation is only marginally greater
than the other RARab–vps (Figs. 4A–E, K–M and 5A1–I1). Overall, the
RARab–vp constructs induced stronger activation of the reporter than
the RARga–vp constructs (Figs. 4A–E, K–M, 5A1–I1, S3 and S4).
Therefore, in the majority of cases, VP16-tagged RARs can activate
ectopic reporter expression.
The reporter expression induced byVP16 fusionproteinswas largely
restricted to areas adjacent to the expression of raldh2, which encodes
themajor RA producing enzyme in the embryo (Begemann et al., 2001;
Grandel et al., 2002). Ectopic ectodermal and notochord expressionwas
primarily restricted to the trunk region and the ventral eye (Figs. 4A–E,
K, L, S3, and S4). This regionalized enhancementof expression suggested
that the VP16-tagged RARs may be acting as ligand-dependent
hyperactive proteins, rather than as truly constitutively active proteins.
To conﬁrm this,we treated Tg(12XRARE-ef1a:gfp) embryos injectedwith
the rar-vpmRNAswith DEAB beginning at 40% epiboly. DEAB treatment
was able to eliminate ectopic activation of the reporter (Figs. 4A–P). This
dependence on the synthesis of RA suggests that the VP16 fusion
proteins are ligand-dependent, so we now refer to these tools as
hyperactive RARs.
We also noticed that the phenotypes induced by hyperactive RARs
were reminiscent of but different than the effects of RA treatment. RA
causes a concentration-dependent posteriorization of the anterior
central nervous system (CNS) (Hernandez et al., 2007). Higher
concentrations of RA can posteriorize embryos and eliminate anterior
structures, while lower concentrations lead to reduction of anteriorA) Schematic composition of RAR constructs used in experiments. (B) Uninjected Tg
rab (C) or rarga (D) mRNA appear normal, and reporter expression is unaffected. (E) Tg
p) embryo injectedwith zebraﬁsh rarab (F) or rarga (G)mRNA and treatedwith 0.05 μM
ior up and dorsal to the right.
Fig. 4. RAR-vps require RA to function. All images depict Tg(12XRARE-ef1a:gfp) embryos. (A, F) Uninjected control embryos. (B–E, K–M) Injection with (B) rarab-Nvp, (C) rarab-ΔAvp,
(D) rarab-Cvp, (E) rarab-ΔFvp, (K) rarga-Nvp, (L) rarga-ΔAvp, or (M) rarga-ΔFvpmRNA induces ectopic reporter expression. (F–P) Treatment with 1 μM DEAB beginning at 40% epiboly
blocks reporter expression in injected embryos. All images are dorsal views with anterior up. (Q) In HEK 293 cells transfected with the pGL3-basic:12XRARE-tk reporter, co-transfection
with RAR-vp constructs caused similar trends of reporter activation to those found in zebraﬁsh embryos. Arbitrary Units (AU) represents the ratio of ﬁreﬂy luciferase to Renilla luciferase.
Each column represents the average AU plus standard deviation (bars) of 3 replicates for a condition from one representative experiment. Equivalent trends were observed using the
pGL3-basic:12XRAR-ef1a reporter; additionally, DEAB treatment of cells transfected with RAR-vp constructs reduced reporter activation (JSW and DY, data not shown).
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8 somites revealed that the full-length RARab–vp proteins were the
most potent, eliminating both the MHB and anterior hindbrain
(Figs. 5B2, D2), compared to just the MHB for the RARab–ΔAvp and
−ΔFvp (Figs. 5C2, E2). Interestingly, of theRARga–vps, theRARga–ΔAvp
did not affect the anterior CNS (Fig. 5G2), while the 3 others all
eliminated the MHB (Figs. 5F2, H2, I2). Despite strong effects on the
MHB and hindbrain, themost anterior CNSwas relatively unaffected by
hyperactive RARs (Fig. 5A2–I2 and S5D-K). This lack of effect on the
most anterior CNS is in contrast to the phenotype caused by RA
treatment (Fig. S6C). Interestingly, the strong effects of the full length
RARab–vps (Nvp and Cvp) on the CNS (Figs. 5B2 and D2) contrast with
the trends observed for activation of the transgenic RARE reporter
(Figs. 5B1 and D1), for which RARab–ΔAvp was the most potent
activator (Fig. 5C1). While the RARga–ΔAvp was the best of the tagged
RARga constructs at activating the transgenic reporter (Fig. 5G1), it did
not affect the CNS (Fig. 5G2). Together, these data show that ectopic
expression of hyperactive RARs does not completely recapitulate the
effects of RA treatment on the anterior CNS, which is likely due to the
ligand-dependency of the hyperactive RARs. Furthermore, when
comparing the effects of particular RARs, there is not a correlation
between the effects of hyperactive RARs on CNS markers and on the
transgenic reporter, given that the RAR-vp constructs that were best at
eliminating CNS structures were not the most potent activators of
transgene expression.
We next looked at the ability of the hyperactive RARs to affect
endogenous targets of RA signaling. We examined two positively
regulated target genes, dhrs3a and hoxb5b, which we have recentlyshown to be downstream and potentially direct targets of RA signaling
(Feng et al., 2010; Waxman et al., 2008; Figs. S4D–I). In contrast to the
generally more potent activation of the transgenic RARE reporter by
RARab–vps, the abilities of the RARab–vps and RARga–vps to induce
ectopic expression of endogenous target genes were quite similar
(Figs. 5A3–5I3, 5A4–5I4). RAR–vps (Nvp,ΔAvp, and Cvp for both RARab
and RARga) induced ectopic expression of the endogenous targets
(Figs. 5B3–D3, F3–H3, B4–D4, F4–H4). Like with transgene expression,
ectopic expression of target genes was usually restricted to the trunk
region of the notochord or to regions adjacent to sites of endogenous
expression (Figs. 5B3–D3, F3–H3, B4–D4, F4–H4). In contrast, the
RAR–ΔFvp fusion proteins (for both RARab and RARga) did not induce
ectopic expression of dhrs3a and hoxb5b, but instead seemed to slightly
reduce their endogenous expression (Figs. 5E3, E4, I3, I4).
For the RAR–vps (Nvp, ΔAvp, and Cvp) that did induce ectopic
expression of the target genes, regions of endogenous expression
were sometimes lost (Figs. 5B4, C4, F4, H4). This suggested that
increasing the amount of RAR–vp expression may also inhibit
endogenous target gene expression. Through titrating the amounts
of rarab–ΔAvp mRNA injected, we found that the lowest concentra-
tions did not affect normal expression and induced ectopic target gene
expression in the notochord, while the highest concentrations
inhibited all expression of target genes (Figs. 6E–L). In contrast to
its effects on target genes, increasing the amount of rarab–ΔAvp
mRNA injected induced stronger reporter expression (Figs. 6A–D).
Altogether, in contrast to the differential abilities of RAR–vps to
activate the RARE transgene, there was little difference between the
abilities of zebraﬁsh RARab–vps and RARga–vps to induce ectopic
Fig. 5. RAR-vps can induce ectopic expression of RA target genes. (A1–I1) Injection of the rar-vpmRNAs differentially activates reporter expression. (A2–I2) Injection of the rar-vpmRNAs, except for rarga-ΔAvp, eliminates the MHB. Cocktail
(cktl) of probes includes opl/zic1 (telencephalon, diencephalic-midbrain boundary), eng2a (MHB), krox20/egr2b (rhombomeres 3 and 5), andmyod (somites and adaxial cells). Arrowheads indicate loss of enr2 expression in the MHB. (A3–I3,
A4–I4) Injection of the rarNvp, rarΔAvp, and rarCvpmRNAs can induce ectopic expression of the RA signaling target genes dhrs3a and hoxb5b, while injection of the rarΔFvpmRNAs inhibits their expression. Arrowheads indicate ectopic dhrs3a
or hoxb5b expression in the notochord. Arrows indicate ectopic dhrs3a expression more anteriorly. (A1–A4) Control uninjected embryos. (B1–B4) rarabNvp mRNA-injected embryos. (C1–C4) rarabΔAvp mRNA-injected embryos. (D1–D4)
rarabCvpmRNA-injected embryos. (E1–E4) rarabΔFvpmRNA-injected embryos. (F1–F4) rargaNvpmRNA-injected embryos. (G1–G4) rargaΔAvpmRNA-injected embryos. (H1–H4) rargaCvpmRNA-injected embryos. (I1–I4) rargaΔFvpmRNA-
injected embryos. All images except A2–I2 are dorsal views with anterior up. Images in A2–I2 are lateral views with dorsal to the right.
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Fig. 6. Injection of high doses of hyperactive RAR mRNA can inhibit target gene expression. Injection of increasing concentrations of rarabΔAvpmRNA increasingly activates reporter
expression (A–D), but inhibits endogenous target gene expression (E–L). (A, E, I) Uninjected control embryos. (B, F, J) In embryos injected with 50 pg of rarabΔAvp mRNA, modest
levels of the reporter are induced (B), as well as ectopic expression of dhrs3a and hoxb5b (arrowheads in F and J). (C, G, K) In embryos injected with 100 pg of rarabΔAvp mRNA,
higher levels of the reporter are induced (C). Although ectopic activation of dhrs3a and hoxb5b is induced (arrowheads in G and K), their endogenous expression is also inhibited
(arrows in G and K). (D, H, L) In embryos injected with 200 pg of rarabΔAvp mRNA, the highest levels of the reporter are induced (D), while endogenous dhrs3a and hoxb5b
expression are inhibited and ectopic expression is not induced (arrowheads in H and L). All images are dorsal views with anterior up.
135J.S. Waxman, D. Yelon / Developmental Biology 352 (2011) 128–140expression of endogenous target genes. However, the inhibition of
target genes by both the RAR–ΔFvps and higher levels of RARab–ΔAvp
emphasize that a proper level of regulation of RAR function is needed
for correct expression of target genes in endogenous locations, which
we postulate is dictated through the availability of co-factors.
Incorporating all of the experiments with RAR–vps, our results
suggest that previously described RAR–vps function as hyperactive
RARs. Importantly, while these function as transcriptional activators
of synthetic RARE reporters, they can also inhibit expression of
endogenous targets. This context-dependence of RAR–vp function
could have signiﬁcance to the interpretation of studies incorporating
these fusion proteins (Blumberg et al., 1997; Koide et al., 2001). Finally,
while we do observe differences between the effects of RARab and
RARga constructs on synthetic reporters, these may be a bit misleading,
as RARab and RARga constructs have similar abilities to affect
endogenous target gene expression in the context of the embryo.
Context-dependent function of dominant negative zebraﬁsh RARs
Having found that hyperactive zebraﬁsh RARs can activate
transcription in the early embryo, we next wanted to test the ability
of the zebraﬁsh RARs to act as transcriptional repressors. We did this
by truncating the majority of the RAR F domain, in the same manner
as for previously reported dominant negative RARs (dnRARs) (Fig. 3;
Damm et al., 1993; Koide et al., 2001). These truncated proteins are
thought to act as dominant transcriptional repressors due to an
inability to release the transcriptional repressive machinery in the
presence of RA (Damm et al., 1993; Koide et al., 2001). In Xenopus,
injection of these constructs has been shown to cause patterning
defects of the anterior CNS consistent with loss of RA signaling
(Blumberg et al., 1997; Koide et al., 2001; Kolm et al., 1997; Sharpe
and Goldstone, 1997). To conﬁrm that the zebraﬁsh dnRARs can
function similarly to the previously studied human and Xenopus
dnRARs, we ﬁrst tested their ability to function in HEK 293 cells.HEK 293 cells appear to exhibit a low level of endogenous
RA signaling that can activate basal levels of the RARE reporters
(Fig. 7A – column 1); this activation is not seen when the RARE sites
have been deleted from the reporter (JSW and DY, unpublished data).
Additionally, transfection of the RA-dependent RAR-vps results in
reporter activation,with similar trends of activation to thoseobserved in
Tg(12XRARE-ef1a:gfp) embryos (Fig. 4Q). In contrast to the benign
effects of injecting WT rarab and rarga mRNA into zebraﬁsh embryos,
both zebraﬁsh RARs were able to stimulate reporter expression in HEK
293 cells upon treatment with RA, although activation by RARga was
consistently less than activation by RARab (Fig. 7B — columns 1–4).
Interestingly,without RA treatment, RARga causedmore of anactivation
of the reporter than did RARab (Fig. 7A — columns 1 and 3). This
difference parallels what has been reported for the human RARa and
RARg (Farboud et al., 2003; Hauksdottir et al., 2003), suggesting that, in
this context, zebraﬁsh RARa and RARg proteins have characteristic
differences that are conserved with other vertebrates.
Having established that the zebraﬁsh RARs are able to activate the
reporter in HEK 293 cells in the presence of RA, we then tested the
ability of zebraﬁsh dnRARs to function as dominant transcriptional
repressors. Alone, the zebraﬁsh and human dnRARs inhibited basal
reporter activation (Fig. 7A— columns 4–6) andwere not activated by
RA treatment (Fig. 7B — columns 5–7). In the presence of zebraﬁsh
RARs (ab and ga), we found that both zebraﬁsh dnRARs (ab and ga),
like the human dnRARa, were able to inhibit RAR function (Figs. 7C —
columns 1–5, and D — columns 1–5).
Because the zebraﬁsh dnRARs could function as dominant transcrip-
tional repressors in this heterologous signaling assay, we next tested if
they could act similarly in the zebraﬁsh embryo. Previous studies have
shown that injection of humandnraramRNA into zebraﬁshembryos can
affect expression of hox genes (Roy and Sagerström, 2004) and that
heat-shock induction of a human dnrara transgene can result in loss of
pectoral ﬁns, abnormal hindbrain patterning and heart enlargement
(Waxman et al., 2008), all of which are characteristic of loss of RA
Fig. 7. Dominant negative RARs can act as transcriptional repressors in HEK 293 cells. (A) Transfection of zebraﬁsh RARab does not affect the basal activation of the reporter (column
2), but transfection of zebraﬁsh RARga causes a modest activation (column 3). Transfection of the dominant negative and Enr fusion proteins inhibits basal activation of the reporter
(columns 4–9). (B) RA treatment of cells transfected with RARab or RARga activates the reporter (columns 2 and 4). RA treatment of HEK 293 cells transfected with any of the
dominant negative proteins or with RARabΔFenr does not activate the reporter (columns 5–8 and 10), while RARabΔAenr modestly activates the reporter (column 9). (C) The
dominant negative and Enr fusion proteins can inhibit the activation of the reporter that is induced by RA treatment of cells transfected with zebraﬁsh RARab. (D) The dominant
negative and Enr fusion proteins can inhibit the activation of the reporter that is induced by RA treatment of cells transfected with zebraﬁsh RARga. All bar graphs reﬂect activation of
the pGL3-basic:12XRAR-ef1a reporter in terms of fold difference of AU and are presented as in Fig. 4.
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human dnrara mRNA caused loss of the pectoral ﬁn, expansion of the
anterior hindbrain, loss of rhombomere 5, and loss of dhrs3a and hoxb5b
expression (Figs. 8A–F, M–R). However, zebraﬁsh embryos injected
with zebraﬁsh dnRARab or dnRARga appeared normal, and expression
of endogenous target geneswas not affected (Figs. 8G–L and S5B,G; JSW
and DY, data not shown). Therefore, it appears that, despite their ability
to function inHEK293 cells, the zebraﬁshdnRARabanddnRARga cannot
function as dominant transcriptional repressors in the context of the
early zebraﬁsh embryo.
Since others have reported the use of a zebraﬁsh dnRARaa (the
paralog of RARab) as a repressor (Stafford and Prince, 2002), we were
hopeful that differences between zebraﬁsh RARaa and RARab could
explain the contextual ability to act as a transcriptional repressor.
However, we found that dnraraa mRNA, like dnrarab mRNA, did not
cause phenotypes consistent with strong loss of RA signaling (JSW and
DY, data not shown), including repression of target genes (Fig. S7C,H),
even thoughboth dnRARaa anddnRARab can function as transcriptional
repressors in cell culture (Figs. 7A–D). Therefore, we cannot completely
rule out that there may be some ability of zebraﬁsh RARs to function as
transcriptional repressors. However, it is likely that the effects of the
zebraﬁsh dnRARaa are minimal, since it needed to be co-injected with
RAR-speciﬁc morpholinos to see a loss of RA signaling phenotype in the
previously reported experiments (Stafford and Prince, 2002).
Due to the high conservation of human and zebraﬁsh RARs, we
were surprised to ﬁnd that the zebraﬁsh dnRARs, unlike human
dnRARa, did not act as dominant transcriptional repressors in the
embryo. It is possible that low levels of expression of exogenous
dnRARs might not be able to interfere with endogenous RAR activity.
Although no tools are currently available to monitor endogenous
zebraﬁsh RAR protein levels, we do not think that the lack of functionof zebraﬁsh dnRARs reﬂects their poor expression, since tagged
versions of zebraﬁsh dnRARs are expressed ubiquitously and robustly
in injected embryos, at levels that we assume to be in excess of the
endogenous RARs (Fig. S2). Therefore, we next tried to increase the
repressive capabilities of zebraﬁsh RARab by replacing either its A or F
domain with the Engrailed repressor (Enr) domain (RARab-ΔAenr
and -ΔFenr; Fig. 3A). We replaced the A and F domains because
replacing them with the VP16 domain in either zebraﬁsh RARab or
RARga had produced some of themore potent hyperactive proteins. In
HEK 293 cells, both RARab-enr proteins were able to inhibit basal
activity of the reporter (Fig. 7A— columns 8 and 9), but RARab-ΔAenr
modestly activated the RARE reporter in the presence of RA (Fig. 7B—
column 9). Interestingly, this modest activation by RARab-ΔAenr is
reminiscent of the activity of the PML-RAR fusion protein implicated
in acute myelogenous leukemia (AML), after which this fusion protein
wasmodeled, which can activate RA targets in the presence of high RA
concentrations (Soprano et al., 2004). Like the zebraﬁsh dnRARs, the
zebraﬁsh RARab-enr proteins were able to inhibit zebraﬁsh RAR
activation of the RARE reporter in HEK 293 cells (Figs. 7C, D; columns
7 and 8). However, as with the zebraﬁsh dnRARs, the zebraﬁsh RARab-
enr constructs did not affect expression of endogenous target genes or
alter embryonic phenotypes (Fig. S7D, E , I, J; JSW and DY, data not
shown). Since even the addition of an Enr domain does not allow
zebraﬁsh RARs to act as dominant transcriptional repressors in the
embryo, it seems likely that the zebraﬁsh RARs are not required to act
as transcriptional repressors in this context.
Discussion
Together, our results indicate that zebraﬁsh RARs function as
context-dependent transcriptional activators. Ectopic expression of
Fig. 8. Zebraﬁsh dnRARab does not act as a transcriptional repressor in zebraﬁsh embryos. (A–F) Uninjected control embryos. (G–L) Embryos injected with zebraﬁsh dnrarab mRNA appear equivalent to uninjected control embryos. (M–R)
Injection of human dnrara mRNA causes phenotypes consistent with loss of RA signaling, including enlarged hearts (arrow in M), loss of pectoral ﬁn (N), loss of rhombomere 5 (arrows in O and P), and loss of endogenous target gene
expression (arrows in Q and R). Phenotypes induces by injection of the human dnrara mRNA are similar to, if not stronger than, those induced when the human dnRARa is expressed from a heat-shock inducible transgene (Waxman et al.,
2008). Cktl of probes is the same as in Fig. 6. (A–C, G–I, M–O) Images are lateral views with dorsal to the right. (D–F, J–L, P–R) Images are dorsal views, anterior up.
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embryo to RA treatment. Hyperactive RARs can activate RA-responsive
targets, although different VP16 fusions exhibit differing abilities to
function depending on the context analyzed. To our surprise, we did not
ﬁnd that zebraﬁsh versions of dominant negative RARs were able to act
as transcriptional repressors in the early embryo, even though a human
dnRAR can produce phenotypes consistent with loss of RA signaling.
Together, our studies suggest that, during early A–P patterning of the
zebraﬁsh embryo, RARs function primarily as transcriptional activators
rather than via a binary repressor–activator mechanism. Thus, it seems
that the binary model for RAR function does not apply to all in vivo
scenarios.
Our analysis of zebraﬁsh RA-responsive transgenes demonstrates
that RARE sites alone cannot recapitulate the expression patterns of all
RA-responsive target genes, such as some anterior hox genes or dhrs3a
(Marletaz et al., 2006; Waxman et al., 2008). The post-gastrulation
initiation of RARE reporter transgene expression in zebraﬁsh, observed
in our studies and by Perz-Edwards et al. (2001), contrasts with the
expression of two similarmouse transgenes,whichbegins in pregastrula
embryos andmore closely recapitulates the expression of known target
genes (Balkan et al., 1992; Perz-Edwards et al., 2001; Rossant et al.,
1991). This contrast suggests the intriguingnotion that there are species-
speciﬁc differences in RARE responsiveness. However, we cannot rule
out the possibility that these differences simply reﬂect position-
dependent inﬂuences upon differentially integrated transgenes.
Restricting the comparison to different zebraﬁsh RA-responsive
transgenes, it seems likely that differences in expression result from
locus-speciﬁc inﬂuences. For example, themore restricted expression of
our reporters, in contrast to the more expansive expression of
previously reported transgenes (Perz-Edwards et al., 2001), may reﬂect
the ability of our longer transgenes to better insulate themselves against
outside inﬂuences. In support of strong context-dependent inﬂuences
on minimal RARE sites, a recent study has examined the zebraﬁsh
cyp26a1 promoter, which is RA-responsive due to two RARE sites, but
whose expression is also known to be controlled by other signaling
pathways (Hu et al., 2008). Transgenes driven by the cyp26a1 promoter
have spatial and temporal expression patterns closely resembling the
early expressionof the endogenous gene,whichdiffer signiﬁcantly from
the expression patterns of the synthetic RARE reporter transgenes
presented here and previously (Perz-Edwards et al., 2001). This further
suggests that other transcription factors, acting either within or outside
the transgene sequences, heavily inﬂuence the temporal and spatial
responsiveness of genes with RARE sites within the zebraﬁsh embryo.
The context-dependent nature of inﬂuences on RARE sites in the
zebraﬁsh embryo ﬁts with the notion that the function of zebraﬁsh
RARs may be highly context-dependent. 3 of the 4 zebraﬁsh RARs
(RARaa, RARab and RARgb) are expressed ubiquitously prior to
gastrulation, while later RARgb is expressed ubiquitously at low levels
(Waxman and Yelon, 2007). Thus, the locations where RA signaling
occurs are likely to be dictated primarily by the availability of RA and
other collaborating factors, rather than by the RARs themselves. We
found multiple distinctions between the abilities of the RARvp fusion
proteins in three different functional assays: RARE reporter transgene
expression, endogenous target gene expression, and CNS patterning
phenotypes. In general, RARab-vps were able to more strongly induce
expression from the transgenic reporter compared to the RARga-vps,
although there were also subtle differences in activation ability
among the RARab-vps and RARga-vps. In contrast to the differences
found with the RARE reporter transgenes, the RARab-vps and RARga-
vps similarly induced the ectopic expression of endogenous target
genes. The endogenous promoters may represent a more permissive
context, which buffers differences between speciﬁc RARs within the
embryo. Because the expression of endogenous target genes can be
repressed by an overload of RAR-vp expression or the lack of an F
domain, coordinated input from other factors must also be necessary
for proper regulation of target gene expression.Most of the hyperactive zebraﬁsh RARs can eliminate the MHB,
similar to the reported effects of increased RA signaling in Xenopus
(Blumberg et al., 1997; Koide et al., 2001). However, recent studies in
zebraﬁsh have not suggested a conserved role for RARs to act as
repressors in the same context, although it cannot be ruled out that
this could be due to an inability to adequately deplete the zebraﬁsh
RARs (Linville et al., 2009). Interestingly, we have found that the
individual zebraﬁsh RAR-vps have differing potency in affecting the
anterior CNS, although these differences did not correlate with their
ability to activate the RARE reporter transgene. These differences in
ability to affect the CNS seem to be additional indicators of context-
speciﬁc modiﬁers at the transcriptional level in the embryo. Together,
the distinctions between the assays revealed by the hyperactive RARs
indicate that transgenic reporter activation can at times bemisleading
relative to the effect on endogenous targets. Thus, multiple conver-
gent assays should be performed to achieve a complete assessment of
RAR function in a given in vivo context.
In contrast to the abilities of the hyperactive RARs, zebraﬁsh dnRARs
are not capable of acting as transcriptional repressors in the early
zebraﬁsh embryo, suggesting that zebraﬁsh RARs may have minimal
endogenous requirement as transcriptional repressors. To our surprise,
even replacing the RARab A- or F-domainswith an Enr domain does not
allow the chimeric proteins to function as transcriptional repressors in
the zebraﬁsh embryo. We have found that fusing the Enr domain to a
zebraﬁsh retinoid X receptor (a related nuclear hormone receptor and
heterodimeric partner of the RARs) can speciﬁcally affect its function
and strongly abrogate normal development when injected into
zebraﬁsh embryos (JSW and DY, unpublished observations), indicating
that the Enr domain can alter transcriptional function ofmembers of the
nuclear hormone family of receptors in zebraﬁsh. Furthermore, both the
zebraﬁsh dnRAR and RAR-enr proteins are able to function as
transcriptional repressors in heterologous cell culture signaling assays.
It is possible that the ineffectiveness of the ectopically expressed dnRAR
and RAR-enr proteins in zebraﬁsh embryos is due to technical
limitations, such as a lack of signiﬁcant overexpression above
endogenous protein levels or variability between expression levels of
different proteins. However, we think these scenarios are unlikely,
based on the observed robust expression of tagged versions of these
proteins (Fig. S2).
What we have found more perplexing is that a human dnRARa can
cause phenotypes resembling loss of RA signaling in the zebraﬁsh
embryo, suggesting it is able to function as a transcriptional repressor
(Roy and Sagerström, 2004; Waxman et al., 2008) in this context. We
presume that there are structural differences between human and
zebraﬁsh RARs that are responsible for their context-dependent
functional differences, but it is not yet clear where these differences
reside. The human and zebraﬁsh dnRARs used are 78% identical and 85%
similar, with most of the differences in the variable A domain and hinge
region/D domain. Initial assessments of human–zebraﬁsh chimeric
dominant negative proteins, made by fusing the human RARa A–C
domains to the D–ΔF domains of the zebraﬁsh RARab dominant
negative protein and vice versa, were not informative, since both
chimeras were able to act as weak dominant negative proteins relative
to thehumandnRARa (Fig. S8). Therefore, it appears that aspects of both
halves of the human protein are required to confer ability to act as a
repressor within the context of the early zebraﬁsh embryo. Future
studies employing additional chimeras will be necessary to discern
which residues are important for the context-speciﬁc differences.
Altogether, the inability of the zebraﬁsh dnRARs to function in the
zebraﬁsh embryo, in contrast to the ability of the human dnRARa,
emphasizes the inherent differences of these homologous proteins and
the limitations of a binary model for RAR function in some develop-
mental contexts.
Together, our data suggest there is signiﬁcant context dependence
for the responsiveness of RA signaling at the transcriptional level.
Putting these results into a broader perspective, such context
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tional regulation of developmental genes in other settings. Elegant
studies of gene regulatory networks in organisms such as Drosophila,
sea urchins, and frogs have demonstrated that precise tissue-speciﬁc
regulation of gene expression often involves multiple cis-regulatory
modules harboring multiple transcriptional elements that correspond
to transcription factors with context-dependent functions (Levine,
2010; Levine and Davidson, 2005; Wilczynski and Furlong, 2010).
Future studies will be aimed at elucidating the precise function of
RARs in a variety of contexts and the nature of their interactions with
partners in cis-regulatory modules containing RAREs.
The acquisition of RA signaling and its control of hox gene expression
has been associated with development of the chordate body plan
(Marletaz et al., 2006). Although RA signaling has been shown to
regulate hox1 expression in amphioxus (Schubert et al., 2005), it has
been shown recently that the thalacian urochordates have lost all of the
major components important for RA signaling (RAR, Cyp26 and Raldh)
and do not require it for A–P patterning (Canestro and Postlethwait,
2007). While ascidian urochordates have retained the RA signaling
machinery, it appears that they may not require RA signaling for A–P
patterning either (Canestro and Postlethwait, 2007). It is clear that RA
signaling is required for A–P patterning in zebraﬁsh (Begemann et al.,
2001; Grandel et al., 2002; Maves and Kimmel, 2005); however, our
results suggest that the regulation of RA target genesmay have a strong
dependence on additional transcriptional regulators in zebraﬁsh
embryos. Based on studies of RA-responsive genes and the more
expansive expression of RARE reporter transgenes inmice (Balkan et al.,
1992; Oosterveen et al., 2003; Rossant et al., 1991; Sharpe et al., 1998),
we also hypothesize that RA signaling in tetrapods may function more
independently at the transcriptional level.
Assimilating the observations from basal chordates, zebraﬁsh, and
tetrapods, we propose two possible models for the evolution of RAR
function. In the ﬁrst model, the ancestral role of RA signaling and RARs
during early A–P patterning could have been subordinate to or
redundant with other necessary transcription factors. If the role of RA
signaling were minimal, acting only in concert with other transcrip-
tion factors in the common chordate ancestor, it would be easier for
these other factors to compensate for loss of RA signaling in the
urochordates and maintain proper embryonic A–P patterning. In
contrast, tetrapod RARs could have become better able to interact
with regulators of transcriptional machinery and therefore less
dependent on interactions with other cis-regulators, allowing RA
signaling to take on a more singular role in regulation of A–P
patterning. Thus, RARs may have evolved from being transcription
factors with minimal singular competence during A–P patterning of
the chordate body plan to having a more pronounced individual role
in tetrapods. Alternatively, in the second model, the manner in which
the zebraﬁsh RARs function could be a derived characteristic of
teleosts, or even zebraﬁsh speciﬁcally. In this scenario, there would be
little or no functional difference between RARs from amphioxus and
mammals, while teleost RARs have lost the ability to act as repressors
in some contexts. Other explanations would therefore be needed to
explain why and how proper A–P patterning is maintained in the
absence of RA signaling in urochordates. Future studies comparing
RARs and the regulation of RA signaling target genes in chordates will
allow for an enhanced understanding of the evolution of RA signaling
and its role in A–P patterning of the chordate body plan.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.01.022.
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